APA (7th ed.) Citation

Terroir, M., Lamesa, C., Krim, M., Vija, L., Texier, J., Cassou-Mounat, T., . . . Courbon, F. (2023). RadioLigand Therapy with [ 177 Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France. Pharmaceuticals (14248247), 16(5), 754. https://doi.org/10.3390/ph16050754

Chicago Style (17th ed.) Citation

Terroir, Marie, Chloé Lamesa, Mehdi Krim, Lavinia Vija, Jean-Sébastien Texier, Thibaut Cassou-Mounat, Jean-Pierre Delord, Delphine Vallot, and Frédéric Courbon. "RadioLigand Therapy with [ 177 Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France." Pharmaceuticals (14248247) 16, no. 5 (2023): 754. https://doi.org/10.3390/ph16050754.

MLA (9th ed.) Citation

Terroir, Marie, et al. "RadioLigand Therapy with [ 177 Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France." Pharmaceuticals (14248247), vol. 16, no. 5, 2023, p. 754, https://doi.org/10.3390/ph16050754.